Abstracts Archive - Page 1159 of 2425 - ACR Meeting Abstracts

Abstract Number: 2317 • 2018 ACR/ARHP Annual Meeting
Characterization of Paget´s Disease of Bone Patients from the South of Portugal (Algarve and Alentejo) – Clinical and Genetic Aspects
Graça Sequeira¹, Pedro Carvalho², Célia Ribeiro¹, Ana Alfaia³, Natércia Conceição⁴ and Leonor Cancela⁴, ¹Rheumatology, University Hospital Center of Algarve, Faro, Portugal, Faro, Portugal, ²Serviço de Reumatologia, Hospitais Universitários de Coimbra, Coimbra, Portugal, Coimbra, Portugal, ³Centre of Marine Sciences, University of Algarve, Faro, Portugal, Faro, Portugal, ⁴Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal, Faro, Portugal
Background/Purpose: Paget’s disease of bone (PDB) is a metabolic bone disorder whose prevalence increases with age and affects ~3% of Caucasian individuals older than 55…
Abstract Number: 2318 • 2018 ACR/ARHP Annual Meeting
Fracture Liaison Service in an Open Health System: Outcomes and Challenges
Donna Jose¹, Karina Torralba², Christina Downey², Micah Yu¹ and Lorena Salto³, ¹Internal Medicine, Loma Linda University Medical Center, Loma Linda, CA, ²Loma Linda University Medical Center, Loma Linda, CA, ³Loma Linda University, Loma Linda, CA
Background/Purpose: The “osteoporosis care gap” is noted by findings that 80% of patients do not receive treatment after an initial fracture. An initial fracture portends…
Abstract Number: 2319 • 2018 ACR/ARHP Annual Meeting
Adherence to Guideline Recommendations for Screening and Treatment of Glucocorticoid Induced Osteoporosis in Patients with Rheumatoid Arthritis on Long Term Glucocorticoid Therapy at a Tertiary Care Center
Patrick Webster¹ and Tarun S. Sharma², ¹Internal Medicine, Allegheny Health Network, Pittsburgh, PA, ²Rheumatology, Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA
Background/Purpose: Glucocorticoid induced osteoporosis (GIOP) is an under-recognized and under-treated condition. Many long-term glucocorticoid (GC) users never receive therapy to prevent bone loss or are…
Abstract Number: 2320 • 2018 ACR/ARHP Annual Meeting
Multimorbidity Is Associated with Hip Fractures in Both Women and Men and across Different Races
Shreyasee Amin¹, Elizabeth J. Atkinson² and Sundeep Khosla², ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Mayo Clinic, Rochester, MN
Background/Purpose: Multimorbidity, the coexistence of 2 or more chronic conditions, is associated with increased disability and poor functional status, and may serve as an important…
Abstract Number: 2321 • 2018 ACR/ARHP Annual Meeting
Dickkopf-1 Serum Levels in Patients with Systemic Sclerosis and Correlation with Trabecular Bone Score
Barbara Ruaro¹, Andrea Casabella², Sabrina Paolino¹, Carmen Pizzorni², Vanessa Smith³, Chiara Seriolo⁴, Luigi Molfetta⁴, Patrizio Odetti⁴ and Maurizio Cutolo², ¹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, San Martino Polyclinic Hospital, Genoa, Italy, Genova, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, ³Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, ⁴Centro di Ricerca su Osteoporosi e Patologie Osteoarticolari CROPO, Di.M.I., Genoa, Italy, Genoa, Italy
Background/Purpose: Dickkopf-1 (DKK1) is a natural inhibitor of Wnt signaling pathway that could be involved in promoting osteoclastogenesis through suppression of osteoprotegerin (1,2). Systemic sclerosis…
Abstract Number: 2322 • 2018 ACR/ARHP Annual Meeting
Intervals of Bone Mineral Density Measurement during Treatment for Osteoporosis in Patients with Rheumatoid Arthritis
Seung Yun Lee¹, Seong Ryul Kwon¹, Mie Jin Lim², Kyong-Hee Jung³ and Won Park⁴, ¹Division of Rheumatology, Department of Internal Medicine, Inha University Hospital, Incheon, Korea, Republic of (South), ²Division of Rheumatology, Departments of Internal Medicine, Inha University Hospital, Incheon, Korea, Republic of (South), ³Rheumatology, Inha University Hospital, Incheon, Korea, Republic of (South), ⁴Medicine/Rheumatology, Inha University Hospital, Incheon, Korea, Republic of (South)
Background/Purpose: There is controversy about the intervals of retesting bone mineral density (BMD) in patients treated for osteoporosis. The objective of this study is to…
Abstract Number: 2323 • 2018 ACR/ARHP Annual Meeting
Predictors of Mortality in Patients with Hip Fragility Fracture
Miguel Guerra¹, Sara Ganhão^2,3, Francisca Aguiar^2,3, Georgina Terroso², Romana Vieira¹, Diana Gonçalves⁴, Tiago Meirinhos⁵, Teresa Martins-Rocha^2,3, Ana Águeda^3,5, Raquel Ferreira^2,3, Miguel Bernardes^2,3, Carlos Vaz^2,3, Raquel Lucas⁶ and Lúcia Costa², ¹Rheumatology, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal, ²Rheumatology, Centro Hospitalar de São João, Oporto, Portugal, ³Faculty of Medicine, Oporto University, Oporto, Portugal, ⁴Rheumatology, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal, ⁵Rheumatology, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal, ⁶Public Health Institute of Oporto University, Oporto, Portugal
Background/Purpose: In Osteoporosis, hip fractures account for significant disease burden, with increased morbi-mortality and financial load on the patient and healthcare system. This study aimed…
Abstract Number: 2324 • 2018 ACR/ARHP Annual Meeting
Predictors of Refracture in Patients with Hip Fragility Fracture
Sara Ganhão^1,2, Miguel Guerra³, Francisca Aguiar^1,2, Georgina Terroso¹, Romana Vieira³, Diana Gonçalves⁴, Teresa Martins-Rocha^2,5, Raquel Ferreira^1,2, Ana Águeda^2,6, Tiago Meirinhos⁷, Eva Mariz^1,2, Raquel Lucas⁸, Miguel Bernardes^1,2, Carlos Vaz^1,2 and Lúcia Costa¹, ¹Rheumatology, Centro Hospitalar de São João, Oporto, Portugal, ²Faculty of Medicine, Oporto University, Oporto, Portugal, ³Rheumatology, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal, ⁴Rheumatology, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal, ⁵Rheumatology Department, Centro Hospitalar de São João, Porto, Portugal, Oporto, Portugal, ⁶Rheumatology, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal, ⁷Serviço de Reumatologia, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal, Aveiro, Portugal, ⁸Public Health, Centro Hospitalar de São João, Oporto, Portugal
Background/Purpose: Hip fractures are associated with substantially elevated morbidity and mortality and thus represent a serious public health problem. The purpose of this study is…
Abstract Number: 2325 • 2018 ACR/ARHP Annual Meeting
Sex Differences in the Association of Frailty and Bone Mineral Density in Patients with Rheumatoid Arthritis
Katherine D. Wysham¹, Dolores M. Shoback², John B. Imboden Jr.³ and Patricia Katz⁴, ¹University of California, San Francisco, San Francisco, CA, ²Medicine, San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴University of California San Francisco, San Francisco, CA
Background/Purpose: Frailty in the general population is associated with poor outcomes including osteoporosis (OP), fracture and death. Frailty occurs at a higher rate in RA…
Abstract Number: 2326 • 2018 ACR/ARHP Annual Meeting
Outcomes One Year after Hip Fracture Repair in the Elderly: Does Social Isolation Matter?
Lisa A. Mandl¹, Serena Lian¹, Jackie Szymonifka², Kirsten Grueter³, Aidan Hadad³ and Joseph Lane³, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Hospital for Special Surgery, New York, NY, ³Orthopaedic Surgery, Hospital for Special Surgery, New York, NY
Background/Purpose: Hip fractures are a serious public health issue with a significant population burden, especially among those over age 65. Social isolation—how integrated a patient…
Abstract Number: 2327 • 2018 ACR/ARHP Annual Meeting
To Screen or Not to Screen?Dexa Ordering Patterns in SLE Patients Who Take Systemic Glucocorticoids
Sara Baig¹, Smarika Sapkota², Anna K. Shmagel³, Parastoo Fazeli⁴, Jeremiah Menk¹ and Ann Marie O'Connell⁵, ¹University of Minnesota, Minneapolis, MN, ²Division of General Internal Medicine, University of Minnesota, Minneapolis, MN, ³Rheumatic & Autoimmune Diseases, University of Minnesota, Minneapolis, MN, ⁴Rheumatology, University of Minnesota, Minneapolis, MN, ⁵University of Minnesota, MInneapolis, MN
Background/Purpose: High doses of glucocorticoids (GC) are often used in the treatment of Systemic Lupus Erythematous (SLE), however, studies suggest that SLE patients do not…
Abstract Number: 2328 • 2018 ACR/ARHP Annual Meeting
Current Factors Associated with Insufficient Vitamin D Status in Patients with Osteoporosis
Sandeep Dhillon¹, Arzoo Alam², Matthew Wong-Pack³, Arthur Lau⁴, Karen A. Beattie⁵ and Jonathan D. Adachi^6,7, ¹Department of Medicine, McMaster University, Hamilton, ON, Canada, ²McMaster University, Hamilton, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴50 Charlton Avenue East, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, ⁵Medicine, McMaster University, Hamilton, ON, Canada, ⁶Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ⁷St Joseph's Healthcare Hamilton, Hamilton, ON, Canada
Background/Purpose: In 2010, the Canadian Osteoporosis guidelines recommended that patients with osteoporosis be supplemented with vitamin D and to achieve serum levels ≥75nmol/L. Past studies,…
Abstract Number: 2329 • 2018 ACR/ARHP Annual Meeting
Carotid Atherosclerosis Is Associated with Compromised Volumetric Bone Mineral Density and Microarchitecture in Patients with Inflammatory Arthritis
Isaac T. Cheng¹, Qing Shang², Edmund Kwok Ming Li², Priscilla Wong¹, Emily WL Kun³, Martin Li⁴, Tena K. Li¹, Tracy Y. Zhu⁵, PW Alex Lee², Ling Qin⁶ and Lai-Shan Tam⁴, ¹Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, Hong Kong, China, ²Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ³Department of Medicine, Tai Po Hospital, Hong Kong, Hong Kong, ⁴Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁵Bone Quality and Health Centre of the Department of Orthopedics & Traumatology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, ⁶Bone Quality and Health Centre of the Department of Orthopedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: Inflammatory arthritis patients had increased risk of atherosclerosis and osteoporosis. The association between presence of carotid plaque and volumetric BMD (vBMD)/microarchitecture is yet to…
Abstract Number: 2330 • 2018 ACR/ARHP Annual Meeting
Vitamin D and Bisphosphonate Therapy in SLE Patients Who Receive Glucocorticoids: Are We Offering the Best Care?
Smarika Sapkota¹, Sara Baig², Toy Hess³, Ann Marie O'Connell⁴, Jeremiah Menk³, Parastoo Fazeli⁵ and Anna K. Shmagel⁶, ¹Division of General Internal Medicine, University of Minnesota, Minneapolis, MN, ²Department of Internal Medicine, University of Minnesota, Minneapolis, MN, ³University of Minnesota, Minneapolis, MN, ⁴University of Minnesota, Minnepolis, MN, ⁵Rheumatology, University of Minnesota, Minneapolis, MN, ⁶Rheumatic & Autoimmune Diseases, University of Minnesota, Minneapolis, MN
Background/Purpose: Glucocorticoids(GC) are frequently used for the treatment of systemic lupus erythematosus (SLE), and glucocorticoid induced osteoporosis (GIOP) is a well-known complication of long term…
Abstract Number: 2331 • 2018 ACR/ARHP Annual Meeting
Obesity Might Positively Affect TNF Mediated Bone Metabolism in RA Patients
Mie Jin Lim¹, Won Park², Seong Ryul Kwon³, Kyong-Hee Jung⁴ and Seung Yun Lee³, ¹Division of Rheumatology, Departments of Internal Medicine, Inha University Hospital, Incheon, Korea, Republic of (South), ²Medicine/Rheumatology, Inha University Hospital, Incheon, Korea, Republic of (South), ³Division of Rheumatology, Department of Internal Medicine, Inha University Hospital, Incheon, Korea, Republic of (South), ⁴Rheumatology, Inha University Hospital, Incheon, Korea, Republic of (South)
Background/Purpose: In this study, we tried to find out the effect of obesity on bone metabolism after one year of anti-TNF agent use. Methods: Thirty-two…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].